Disrupted Adderall Access Poses Risks After Telehealth Company Charged with Fraud
Tens of thousands of patients with attention deficit hyperactivity disorder nationwide could face disruptions to their care after two executives of a major telehealth company that distributed A.D.H.D. drugs were indicted on charges of health care fraud. The Department of Justice announced on Thursday that the chief executive and the clinical president of Done, the…